However, CCR5 expression was reduced, and both chemokine CCL3 and CCL4 chemokine expression levels were augmented in amyloid precursor protein plus presenilin-1 (APP/PS1) mice, which are a common model for AD studies (Obrador et al., 2019). This evidence concerns the gene CCR5 and Alzheimer disease.